VistaGen Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $183 | $84 | $197 | $411 |
Gross Profit | 183 | -67 | 50 | 268 |
EBITDA | -14,070 | -11,980 | -11,326 | -7,852 |
EBIT | -14,227 | -12,131 | -11,473 | -7,995 |
Net Income | -12,961 | -10,733 | -9,521 | -6,349 |
Net Change In Cash | 183 | 84 | 197 | 411 |
Free Cash Flow | -10,844 | -10,911 | -7,225 | -4,567 |
Cash | 84,246 | 102,918 | 119,166 | 126,559 |
Basic Shares | 30,632 | 30,603 | 27,029 | 14,698 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $1,064 | $-227 | $1,108 | $1,089 |
Gross Profit | 496 | -227 | 293 | 1,089 |
EBITDA | -32,453 | -58,736 | -46,943 | -17,801 |
EBIT | -33,021 | -59,268 | -47,759 | -17,918 |
Net Income | -29,362 | -59,247 | -47,762 | -17,934 |
Net Change In Cash | 1,064 | -227 | 1,108 | 1,089 |
Cost of Revenue | -34,973 | 101,753 | ||
Free Cash Flow | -25,874 | -49,927 | -45,456 | -12,348 |
Cash | 119,166 | 16,637 | 68,135 | 103,108 |
Basic Shares | 19,354 | 6,958 | 6,599 | 2,871 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.42 |
2024-06-30 | -$0.35 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.22 |
